CASI Pharmaceuticals (CASI) Enterprise Value (2021 - 2025)
Historic Enterprise Value for Pharmaceuticals (CASI) over the last 5 years, with Q2 2025 value amounting to -$6.7 million.
- Pharmaceuticals' Enterprise Value fell 7060177.28% to -$6.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$6.7 million, marking a year-over-year decrease of 7060177.28%. This contributed to the annual value of -$13.5 million for FY2024, which is 5370.87% up from last year.
- Pharmaceuticals' Enterprise Value amounted to -$6.7 million in Q2 2025, which was down 7060177.28% from -$10897.0 recorded in Q1 2025.
- Over the past 5 years, Pharmaceuticals' Enterprise Value peaked at -$9533.0 during Q2 2024, and registered a low of -$19.9 billion during Q2 2023.
- For the 5-year period, Pharmaceuticals' Enterprise Value averaged around -$2.2 billion, with its median value being -$13.5 million (2024).
- Per our database at Business Quant, Pharmaceuticals' Enterprise Value skyrocketed by 10000.0% in 2024 and then tumbled by 7060177.28% in 2025.
- Over the past 5 years, Pharmaceuticals' Enterprise Value (Quarter) stood at -$25.1 million in 2021, then fell by 4.38% to -$26.2 million in 2022, then dropped by 10.98% to -$29.1 million in 2023, then soared by 53.71% to -$13.5 million in 2024, then surged by 49.96% to -$6.7 million in 2025.
- Its Enterprise Value was -$6.7 million in Q2 2025, compared to -$10897.0 in Q1 2025 and -$13.5 million in Q4 2024.